Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates

Journal of Molecular Biology

Volumn 351, Issue 4, 2005, Pages 910-922

  Plakoutsi, Georgia ^a   Bemporad, Francesco ^a   Calamai, Martino ^b   Taddei, Niccolò ^a   Dobson, Christopher M ^b   Chiti, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aggregation intermediates; Disease; Misfolding; Oligomerisation; On pathway

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CONGO RED; THIOFLAVINE;

ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; INFRARED SPECTROSCOPY; KINETICS; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; SULFOLOBUS SOLFATARICUS; TRANSMISSION ELECTRON MICROSCOPY;

SULFOLOBUS SOLFATARICUS;

EID: 23444447864     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.06.043     Document Type: Article

References (53)

1. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890
2. M. Stefani, and C.M. Dobson Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J. Mol. Med. 81 2003 678 699
3. V.N. Uversky, and A.L. Fink Conformational constraints for amyloid fibrillation: the importance of being unfolded Bioch. Biophys. Acta 1698 2004 131 153
4. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, and J. Zurdo Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
5. M. Bucciantini, G. Calloni, F. Chiti, L. Formigli, D. Nosi, C.M. Dobson, and M. Stefani Pre-fibrillar amyloid protein aggregates share common features of cytotoxicity J. Biol. Chem. 279 2004 31374 31382
6. D.J. Selkoe Folding proteins in fatal ways Nature 426 2003 900 904
7. J.D. Harper, S.S. Wong, C.M. Lieber, and P.T. Lansbury Observation of metastable Abeta amyloid protofibrils by atomic force microscopy Chem. Biol. 4 1997 119 125
8. J.D. Harper, C.M. Lieber, and P.T. Lansbury Jr Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein Chem. Biol. 4 1997 951 959
9. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, and D.B. Teplow Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate J. Biol. Chem. 272 1997 22364 22372
10. D.M. Walsh, D.M. Hartley, Y. Kusumoto, Y. Fezoui, M.M. Condron, and A. Lomakin Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates J. Biol. Chem. 274 1999 25945 25952
11. C. Ionescu-Zanetti, R. Khurana, J.R. Gillespie, J.S. Petrick, L.C. Trabachino, and L.J. Minert Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy Proc. Natl Acad. Sci. USA 96 1999 13175 13179
12. M. Bouchard, J. Zurdo, E.J. Nettleton, C.M. Dobson, and C.V. Robinson Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy Protein Sci. 9 2000 960 967
13. K.A. Conway, J.D. Harper, and P.T. Lansbury Jr Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid Biochemistry 39 2000 2552 2563
14. T.R. Serio, A.G. Cashikar, A.S. Kowal, G.J. Sawicki, J.J. Moslehi, and L. Serpell Nucleated conformational conversion and the replication of conformational information by a prion determinant Science 289 2000 1317 1321
15. A. Quintas, D.C. Vaz, I. Cardoso, M.J.M. Saraiva, and R.M.M. Brito Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants J. Biol. Chem. 276 2001 27207 27213
16. H.A. Lashuel, D. Hartley, B.M. Petre, T. Walz, and P.T. Lansbury Jr Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
17. M.A. Poirier, H. Li, J. Macosko, S. Cail, M. Amzel, and C.A. Ross Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrillization J. Biol. Chem. 277 2002 41032 41037
18. A. Relini, S. Torrassa, R. Rolandi, A. Gliozzi, C. Rosano, and C. Canale Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils J. Mol. Biol. 338 2004 943 957
19. L.A. Morozova-Roche, V. Zamotin, M. Malisauskas, A. Ohman, R. Chertkova, and M.A. Lavrikova Fibrillation of carrier protein albebetin and its biologically active constructs multiple oligomeric intermediates and pathways Biochemistry 43 2004 9610 9619
20. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, and P.M. Vassilev Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884
21. D.M. Walsh, and D.J. Selkoe Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Pept. Letters 11 2004 213 228
22. M.D. Kirkitadze, G. Bitan, and D.B. Teplow Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
23. G. Bitan, A. Lomakin, and D.B. Teplow Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins J. Biol. Chem. 276 2001 35176 35184
24. G. Bitan, M.D. Kirkitadze, A. Lomakin, S.S. Vollers, G.B. Benedek, and D.B. Teplow Amyloid β-protein (Aβ) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways Proc. Natl Acad. Sci. USA 100 2003 330 335
25. A.E. Roher, M.O. Chaney, Y.M. Kuo, S.D. Webster, W.B. Stine, and L.J. Haverkamp Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease J. Biol. Chem. 271 1996 20631 20635
26. M.B. Podlisny, B.L. Ostaszewski, S.L. Squazzo, E.H. Koo, R.E. Rydell, D.B. Teplow, and D.J. Selkoe Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture J. Biol. Chem. 270 1995 9564 9570
27. D.M. Walsh, B.P. Tseng, R.E. Rydel, M.B. Podlisny, and D.J. Selkoe The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain Biochemistry 39 2000 10831 10839
28. G. Plakoutsi, N. Taddei, M. Stefani, and F. Chiti Aggregation of the acylphosphatase from Sulfolobus solfataricus: the folded and partially unfolded states can both be precursors for amyloid formation J. Biol. Chem. 279 2004 14111 14119
29. D.W. Grogan Phenotypic characterization of the archaeal genus Sulfolobus: comparison of five wild-type strains J. Bacteriol. 171 1989 6710 6719
30. F. Chiti, P. Webster, N. Taddei, A. Clark, M. Stefani, G. Ramponi, and C.M. Dobson Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc. Natl Acad. Sci. USA 96 1999 3590 3594
31. S. Srisailam, T.K. Kumar, D. Rajalingam, K.M. Kathir, H.S. Sheu, and F.J. Jan Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation J. Biol. Chem. 278 2003 17701 17709
32. C.J. Barrow, and M.G. Zagorski Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition Science 253 1991 179 182
33. F. Chiti, N. Taddei, M. Bucciantini, P. White, G. Ramponi, and C.M. Dobson Mutational analysis of the propensity for amyloid formation by a globular protein EMBO J. 19 2000 1441 1449
34. Y. Fezoui, and D.B. Teplow Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization J. Biol. Chem. 277 2002 36948 36954
35. F. Chiti, M. Stefani, N. Taddei, G. Ramponi, and C.M. Dobson Rationalisation of the effects of mutations on peptide and protein aggregation rates Nature 424 2003 805 808
36. L.A. Munishkina, C. Phelan, V.N. Uversky, and A.L. Fink Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes Biochemistry 42 2003 2720 2730
37. A. Corazza, C. Rosano, K. Pagano, V. Alverdi, G. Esposito, and C. Capanni Structure, conformational stability and enzymatic properties of acylphosphatase from the hyperthermophile Sulfolobus solfataricus Proteins: Struct. Funct. Genet 2005 In the press
38. A. Lomakin, G.B. Benedek, and D.B. Teplow Monitoring protein assembly using quasielastic light scattering spectroscopy Methods Enzymol. 309 1999 429 459
39. F. Sokolowski, A.J. Modler, R. Masuch, D. Zirwer, M. Baier, and G. Lutsch Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein J. Biol. Chem. 278 2003 40481 40492
40. W.C. Johnson Jr Protein secondary structure and circular dichroism: a practical guide Proteins: Struct. Funct. Genet. 7 1990 205 214
41. S.Yu. Venyaminov, and K.S. Vassilenko Determination of protein tertiary structure class from circular dichroism spectra Anal. Biochem. 222 1994 176 184
42. F. Bemporad, C. Capanni, M. Calamai, M.L. Tutino, M. Stefani, and F. Chiti Studying the folding process of the acylphosphatase from Sulfolobus solfataricus. A comparative analysis with other proteins from the same superfamily Biochemistry 43 2004 9116 9126
43. M.J. Volles, S.J. Lee, J.C. Rochet, M.D. Shtilerman, T.T. Ding, J.C. Kessler, and P.T. Lansbury Jr Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease Biochemistry 40 2001 7812 7819
44. W.E. Klunk, J.W. Pettegrew, and D.J. Abraham Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation J. Histochem. Cytochem. 37 1989 1273 1281
45. H. LeVine III Quantification of beta-sheet amyloid fibril structures with thioflavin T Methods Enzymol. 309 1999 274 284
46. J.J. Kremer, M.M. Pallitto, D.J. Sklansky, and R.M. Murphy Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes Biochemistry 39 2000 10309 10318
47. P.O. Souillac, V.N. Uversky, and A.L. Fink Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN Biochemistry 42 2003 8094 8104
48. J.S. Pedersen, G. Christensen, and D.E. Otzen Modulation of S6 fibrillation by unfolding rates and gatekeeper residues J. Mol. Biol. 341 2004 575 588
49. L. Bousset, N.H. Thomson, S.E. Radford, and R. Melki The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro EMBO J. 17 2002 2903 2911
50. E. Laurine, C. Gregoire, M. Fandrich, S. Engemann, S. Marchal, and L. Thion Lithostathine quadruple helical filaments form proteinase-K resistant deposits in Creutzfeldt-Jakob disease J. Biol. Chem. 278 2003 51770 51778
51. L. Bousset, F. Briki, J. Doucet, and R. Melki The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils J. Struct. Biol. 141 2003 132 142
52. G. Camici, G. Manao, G. Cappugi, and G. Ramponi A new synthesis of benzoyl phosphate: a substrate for acyl phosphatase assay Experientia 32 1976 535 536
53. N. Taddei, M. Stefani, F. Magherini, F. Chiti, A. Modesti, G. Raugei, and G. Ramponi Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42 and Thr46 Biochemistry 35 1996 7077 7083